2022Upcoming events202420232022202120202019201820172016All years January 27, 2022 12:00 CET Deep dive presentation of the design of the phase III study CONCLUDE at HC Andersen Capital’s online event Add to calendar February 23, 2022 Year-end Report 2021 Add to calendar February 24, 2022 Deep dive into the mechanism of action of cobitolimod at HC Andersen Capital’s online event Add to calendar March 31, 2022 Presentation at Redeye Investor Forum in Malmö Add to calendar April 8, 2022 Annual Report 2021 Add to calendar May 16, 2022 Interim Report Q1 2022 Add to calendar June 1, 2022 Annual General Meeting 2022 Add to calendar June 2, 2022 Presentation at Redeye Growth Day Add to calendar June 9, 2022 Deep dive presentation: commercialisation strategy for cobitolimod at HC Andersen Capital’s online event Add to calendar August 26, 2022 Interim Report Q2 2022 Add to calendar September 7, 2022 Presentation at Pareto Securities Healthcare Conference Add to calendar September 22, 2022 Presentation and Q&A – the positive feedback from PMDA by acting CEO Johan Giléus and CMO Anders Bröijersen at HC Andersen Capital Add to calendar October 6, 2022 Presentation at Redeye investor AW in Gothenburg Add to calendar October 8 - October 11, 2022 InDex Pharmaceuticals to exhibit at UEGW Add to calendar November 23, 2022 Interim Report Q3 2022 Add to calendar November 24, 2022 Presentation at Redeye Life Science Day 2022 Add to calendar
January 27, 2022 12:00 CET Deep dive presentation of the design of the phase III study CONCLUDE at HC Andersen Capital’s online event Add to calendar
February 24, 2022 Deep dive into the mechanism of action of cobitolimod at HC Andersen Capital’s online event Add to calendar
June 9, 2022 Deep dive presentation: commercialisation strategy for cobitolimod at HC Andersen Capital’s online event Add to calendar
September 22, 2022 Presentation and Q&A – the positive feedback from PMDA by acting CEO Johan Giléus and CMO Anders Bröijersen at HC Andersen Capital Add to calendar